Dr. Martin Roche is an orthopedic surgeon. He specializes in knee and hip replacements. Roche said he now recommends GLP1 weight loss drugs for many of his patients. "We have definitely seen patients ...

If we could develop a medication that helps maintain fat or sugar burning at its original high level alongside weight-loss ...

While Silicon Valley obsesses over AI, Wildfire Labs founder Todd Gagne argues that GLP-1 medications represent a much ...

The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

The obesity medicine field has gained a new entrant, with AbbVie licensing an experimental drug from a Danish company.

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

A legal dispute over tirzepatide’s availability is reshaping diabetes and weight loss treatment access, raising concerns for ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

In a continued fundraising effort for its integrated health care center, MarillacHealth launched a public campaign to secure ...

While the bulk (pun intended) of news coverage these days is focused on GLP-1 drugs like Ozempic that cause weight loss, licensed pharmacist Dr. Kati Forbes told The Post four medications are ...

Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...

That's a potential steal. The average stock in the Health Care Select Sector SPDR Fund trades at a multiple of just under 18 ...